RETREG1 and metastatic malignant neoplasm in the lymph nodes: There was a higher prevalence of FAM134B methylation among patients with lymph node metastasis (75% of patients) and those exhibiting LVI (68% of LVI-positive patients) when compared to patients without any lymph node metastasis or LVI-negative patients [57].